Insights into Company Bills & Payments

Bio Green Med Solution Inc.

Biotechnology: Pharmaceutical Preparations company

📍 United States NASDAQ BGMS Pharmaceuticals & Healthcare
Search companies

Key Metrics of Bio Green Med Solution Inc.

Revenue₹0▼ 100.0% YoYFY 2025-26
EBITDA−₹75.7 Cr▲ 26.3% YoY
Net profit−₹26.9 Cr▲ 71.9% YoY
Net worth₹61.5 Cr▲ 430.4% YoY
Market cap$6.0MBGMS · $0.90
Competitors10identified

About Bio Green Med Solution Inc.

Sectors

Pharmaceuticals & HealthcareBiotechnology & Vaccines

Company details

Listed
Nasdaq: BGMS

Operational Areas of Bio Green Med Solution Inc.

Pharmaceuticals & Healthcare›Biotechnology & Vaccines

Company summary

Legal nameBio Green Med Solution Inc.
TickerBGMS
ExchangeNasdaq
CountryUnited States
SEC CIK0001130166
Listed since—
IndustryBiotechnology: Pharmaceutical Preparations
SectorPharmaceuticals & Healthcare · Biotechnology & Vaccines
Website—

US market & SEC filings

BGMS · Nasdaq  ·  SEC CIK 0001130166

Last price · 02 Nov 2026 $0.90 +8.43%
Market cap$6.0M
P/E—On FY 2023 diluted EPS
Volume11,525
SectorHealth CareBiotechnology: Pharmaceutical Preparations
Country · IPOUnited States

BGMS share price

Premium

Annual results (SEC EDGAR)

Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.

Sign in to continue See plans & pricing
Premium

Financials, ratios and risk analysis

Revenue, EBITDA, net profit, net worth, debt and assets for every filing year, 15+ ratios, the financial health score, shareholding, charges and peer comparison are part of the premium plan.

Sign in to continue See plans & pricing

Vendor checks & payment capacity

Sign in with access to company financials to review vendor evidence.

Credit assessment · Manufacturing

Rating Methodology – Manufacturing Companies (Mar 2025) · Consolidated accounts · FY 2025-26

Indicative long-term—
Indicative short-term—
Score—
LiquidityAdequate
DirectionStable

Ratios, pillar scores and the indicative rating are part of Premium.

Rating status

DefaultNo default on record
Issuer cooperationCooperating
Credit enhancementNone – standalone rating
Information on file22% · missing: Annual results history (3+ years), Debt obligations and repayment schedule, Capex / investment plans, Lender details, Auditor details, Shareholding pattern, Recent rating review (last 15 months)

Indicative assessment from public data using the published methodology factors; not a credit rating.

Registered office and contact

Registered office—
GSTIN—
Email—
Website—
Members / shareholders—

Directors and key people

Directors are read from the MGT-7 annual return and AOC-4 signatories.

Competitors of Bio Green Med Solution Inc.

Competitors10identified
Countries1most in United States

Top competitors by location

CompanyDescriptionDomainFoundedLocation
Vertex Pharmaceuticals Part of Vertex Pharmaceuticals. vrtx.com 1991 United States
Moderna Biotechnology & Vaccines · Pharmaceuticals & Healthcare modernatx.com 2018 United States
Becton Dickinson Biotechnology & Vaccines · Pharmaceuticals & Healthcare bd.com — United States
Illumina Part of Illumina. illumina.com 2000 United States
Guardant Health Biotechnology & Vaccines · Pharmaceuticals & Healthcare guardanthealth.com 2018 United States
Revvity Inc. Biotechnology & Vaccines · Pharmaceuticals & Healthcare revvity.com — United States
Exelixis Biotechnology & Vaccines · Pharmaceuticals & Healthcare exelixis.com 2000 United States
Neurocrine Biosciences Biotechnology & Vaccines · Pharmaceuticals & Healthcare neurocrine.com 1996 United States
Twist Bioscience Biotechnology & Vaccines · Pharmaceuticals & Healthcare twistbioscience.com 2018 United States
BioMarin Pharmaceutical Biotechnology & Vaccines · Pharmaceuticals & Healthcare biomarin.com 1999 United States

Similar companies

Charges (secured borrowings)

0 registered charges. Lenders, amounts and dates are part of the premium plan.

Statutory auditors

Auditors are read from the AOC-4 auditor's report section.

Business activities and related parties

Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.

Filings

No filings on record yet.